A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis

NCT07027163 · clinicaltrials.gov ↗
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Novartis Pharmaceuticals